Seer (SEER) Depreciation & Amortization (CF) (2020 - 2026)
Seer (SEER) recorded quarterly Depreciation & Amortization (CF) of $1.5 million in Q1 2026, up 1.33% quarter-over-quarter from $1.5 million in Q4 2025, and down 4.44% on a YoY basis from $1.6 million in Q1 2025.
Seer (SEER) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Seer's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 4.44% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $6.0 million (down 3.93% YoY), while the FY2025 annual figure was $6.1 million, down 1.17% from the prior year.
- Depreciation & Amortization (CF) was $1.5 million for Q1 2026 at Seer, up from $1.5 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.6 million in Q4 2024 to a low of $875000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $1.4 million across 5 years, with a median of $1.5 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 81.54% in 2022, then decreased 7.44% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.1 million in 2022, then surged by 43.25% to $1.6 million in 2023, then climbed by 1.77% to $1.6 million in 2024, then slipped by 6.28% to $1.5 million in 2025, then grew by 1.33% to $1.5 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1,395.22 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 429,663.65 |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | 1.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.51 Mn |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Dec 31, 2023 | 1.58 Mn |